PHARMARESEARCH BIO Co., Ltd. (XKON:217950)

South Korea flag South Korea · Delayed Price · Currency is KRW
35,650
-50 (-0.14%)
At close: Aug 22, 2025, 3:30 PM KST
-0.14%
Market Cap149.04B
Revenue (ttm)178.19M
Net Income (ttm)-883.52M
Shares Out4.18M
EPS (ttm)-22,088.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,875
Average Volume3,643
Open35,700
Previous Close35,700
Day's Range34,950 - 35,850
52-Week Range26,700 - 50,000
Beta0.35
RSI47.21
Earnings Daten/a

About PHARMARESEARCH BIO

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide. The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65. It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The co... [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 217950
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.